Showing results (61-70 of 125) with videos related to
Sort By:
Pageof 13
Voprosy Kurortologii, Fizioterapii, I Lechebnoi Fizicheskoi Kultury|May 4, 2023
[Medical rehabilitation of patients with spinal muscular atrophy]G N Ponomarenko, I S Maltsev, A A Koltsov, et al.Eye (London, England)|March 22, 2025
Status of papillomacular bundle in optic disc pit associated with maculopathyDmitrii S Maltsev, Alexei N Kulikov, Yana A Kalinicheva, et al.Journal of Current Ophthalmology|August 19, 2021
Characteristics of Central Serous Chorioretinopathy without LeakageDeepika C Parameswarappa, Dmitrii S Maltsev, Abhilash Goud, et al.Seminars in Ophthalmology|July 2, 2019
Choroidal Changes at the Leakage Site in Acute Central Serous ChorioretinopathyNiroj Kumar Sahoo, Dmitrii S Maltsev, Abhilash Goud, et al.International Journal of Retina and Vitreous|August 29, 2018
Direct navigated laser photocoagulation as primary treatment for retinal arterial macroaneurysmsDmitrii S Maltsev, Alexei N Kulikov, Bhushan Uplanchiwar, et al.Seminars in Ophthalmology|May 5, 2021
Retinal Pigment Epithelium Reflectivity at Leakage Site on Spectral-Domain Optical Coherence Tomography in Acute Central Serous ChorioretinopathyDmitrii S Maltsev, Alexei N Kulikov, Maria A Burnasheva, et al.International Ophthalmology|December 5, 2019
Structural en face optical coherence tomography imaging for identification of leaky microaneurysms in diabetic macular edemaDmitrii S Maltsev, Alexei N Kulikov, Maria A Burnasheva, et al.Eye (London, England)|January 24, 2020
Axial length as a basic anatomical predictor for morphological and clinical characteristics in acute central serous chorioretinopathyDmitrii S Maltsev, Alexei N Kulikov, Maria A Burnasheva, et al.Protein Science : a Publication of the Protein Society|July 1, 2014
A maximum entropy approach to the study of residue-specific backbone angle distributions in α-synuclein, an intrinsically disordered proteinAlexey B Mantsyzov, Alexander S Maltsev, Jinfa Ying, et al.BMC Ophthalmology|July 29, 2024
A phase III, multicentre, randomised, investigator-masked, cross-over, comparative, non-inferiority trial evaluating the efficacy and tolerability of generic preservative-free Latanoprost (Polpharma S.A.) compared to Xalatan® (Pfizer) in patients with ocular hypertension or primary open-angle glaucomaNorbert Czumbel, Tamas Acs, Gyorgy Bator, et al.Pageof 13